In “TMB-H with MSS” tumors, the ratio of genomic alterations in PIK3CA was the most or the second highest, which was 61.1% in endometrial, 51.4% in cervical, and 31.0% in ovarian cancers (Supplementary Figure S3). Here, PIK3CA is linked to ovarian cancer.